UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023311
Receipt number R000026773
Scientific Title Randomized control study of the usability of vessel sealing devices at the time of pancreatoduodenectomy
Date of disclosure of the study information 2016/07/26
Last modified on 2021/01/31 19:16:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized control study of the usability of vessel sealing devices at the time of pancreatoduodenectomy

Acronym

Randomized control study of the usability of vessel sealing devices at the time of pancreatoduodenectomy

Scientific Title

Randomized control study of the usability of vessel sealing devices at the time of pancreatoduodenectomy

Scientific Title:Acronym

Randomized control study of the usability of vessel sealing devices at the time of pancreatoduodenectomy

Region

Japan


Condition

Condition

Diseases which required pancreas head resection

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Some reports advocated the valuable usability of surgical energy devices to reduce operative time and blood loss. However there were no comparative analysis of surgical energy devises. Therefore we have planed a randomized controlled study of surgical energy devices to evaluate its usability and safeness.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Subjective evaluation of sealing devices by surgeon (questionnaire survey)

Key secondary outcomes

1.Operative time and intra-operative blood loss
2.Postoperative complications
3.Quantity of drainaged fluid at postoperative day 1 and 2.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

LigaSure Small Jaw produced by COVIDIEN JAPAN
Intervention during operation time of pancreatoduodenectomy

Interventions/Control_2

Harmonic FOCUS produced by Johnson and Johnson
Intervention during operation time of pancreatoduodenectomy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

#1 20 years old or more at the time of agreement of participation for this study.
#2 Patients who understood well about this study and agreed to the participation for this study.

Key exclusion criteria

#1Unresectable cases after registration to this study
#2patients who have liver cirrhosis
#3Patients who required anti coagulation therapy during perioperative time.
#4patients who was considered as inadequate by principal researcher

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Sohei
Middle name
Last name Satoi

Organization

Kansai Medical University

Division name

Surgery

Zip code

5731010

Address

2-5-1 SHinmachi, Hirakata city, Osaka 573-1010 Japan

TEL

0728041010

Email

satoi@hirakata.kmu.ac.jp


Public contact

Name of contact person

1st name Sohei
Middle name
Last name Satoi

Organization

Kansai Medical University

Division name

Surgery

Zip code

5731010

Address

2-5-1 SHinmachi, Hirakata city, Osaka 573-1010 Japan

TEL

0728041010

Homepage URL


Email

satoi@hirakata.kmu.ac.jp


Sponsor or person

Institute

Kansai Medical University

Institute

Department

Personal name



Funding Source

Organization

Kansai Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kansai Medical University

Address

Shinmachi2-5-1,HirakataOsaka city, Osaka

Tel

0728041010

Email

satoi@hirakata.kmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 26 Day


Related information

URL releasing protocol

unpublished

Publication of results

Unpublished


Result

URL related to results and publications

unpublished

Number of participants that the trial has enrolled

100

Results

unpublished

Results date posted

2021 Year 01 Month 31 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

unpublished

Participant flow

unpublished

Adverse events

unpublished

Outcome measures

unpublished

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 03 Month 04 Day

Date of IRB

2016 Year 06 Month 27 Day

Anticipated trial start date

2016 Year 07 Month 26 Day

Last follow-up date

2018 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 07 Month 24 Day

Last modified on

2021 Year 01 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026773


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name